Metric Finance
LearnFAQ
LearnFAQ

Learn / ASND

NASDAQ: ASND

Ascendis Pharma A/S (ASND) stock, explained like you're 5

Ascendis Pharma A/S trades on the Nasdaq under the ticker ASND. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 15.1 billion dollars.

Ticker
ASND
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 15.1 billion dollars

Is Ascendis Pharma A/S a small, medium or large cap company?

Yes. Ascendis Pharma A/S is a large cap stock. Its market cap, which is the total value of all its shares, is about 15.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Ascendis Pharma A/S makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ASND stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Ascendis Pharma (ASND) Stock May Be Undervalued After Rare Disease Data News (Simply Wall Street)
  • ASND Shares Shrug Off Positive European Opinion For FDA Approved Achondroplasia Drug (TradingView)
  • EU advisers weigh in on once weekly TransCon CNP for children at Ascendis Pharma (ASND) (Stock Titan)
  • ASND Nov 2026 180.000 call (ASND261120C00180000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Employees receive 35,890 warrants from Ascendis Pharma (ASND) at a $223.21 exercise price. (Stock Titan)

Follow ASND in your daily brief

Each trading day at 5 PM ET we post what happened to Ascendis Pharma A/S and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ASND

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Ascendis Pharma A/S stock

What does Ascendis Pharma A/S do?

Ascendis Pharma A/S trades on the Nasdaq under the ticker ASND. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 15.1 billion dollars.

What is the ticker symbol for Ascendis Pharma A/S?

Ascendis Pharma A/S trades under the ticker ASND on the Nasdaq.

What is Ascendis Pharma A/S's market cap?

Ascendis Pharma A/S is a large cap stock with a market cap of about 15.1 billion dollars.

How does Ascendis Pharma A/S make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ASND stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ASND stock every day?

Add ASND to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ASND daily

A free brief on Ascendis Pharma A/S and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ASND: ASND vs NVS, ASND vs AZN, ASND vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed